Conformation-Switching Fluorescent Probe for Alpha Synuclein Oligomer Detection

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods lack the capability for rapid, specific, and quantitative detection of alpha synuclein (αS) oligomers, which are major toxic agents in Parkinson's disease, due to their structurally transient nature and similarity to other αS aggregates, leading to incomplete prevention of fibrillization and accumulation of oligomers.

Innovation Solution

Engineering a conformation-switching protein probe, PG65, an αS variant with a tetracysteine motif, that generates fluorescence signals linked to αS aggregation states, allowing for selective detection of high molecular weight αS oligomers using conformation-sensitive fluorescence.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional detection methods are used for alpha synuclein aggregates, then detection can be performed, but specificity for oligomers is lost due to structural similarity between oligomers and fibrils

Engineering Contradiction:

Improvespecificity for alpha synuclein oligomersVSAvoiddetection method complexity

Core Design Contradiction:

Measurement precisionVSDevice complexity

Solution Approach 1:

The probe PG65 incorporates a localized conformational switch element within its structure that specifically responds to the unique structural features of alpha synuclein oligomers. This local structural feature enables selective detection of oligomers without requiring complex overall probe design, resolving the contradiction between measurement precision and device complexity.

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The invention utilizes conformational changes in the PG65 probe structure upon binding to alpha synuclein oligomers. The probe transitions from a disordered state to a structured state specifically when bound to oligomers, generating a detectable fluorescence signal. This parameter change approach enables specific oligomer detection without complex instrumentation.

Inventive Principle:

Principle #35Parameter changes

2Speed

If detection methods are designed to be rapid-responsive, then transient oligomers can be detected, but quantitative specificity is compromised

Engineering Contradiction:

Improvedetection response timeVSAvoidquantitative specificity for oligomers

Core Design Contradiction:

SpeedVSMeasurement precision

Solution Approach 1:

The PG65 probe is pre-engineered with an intrinsically disordered region that is primed to undergo conformational switching upon encounter with alpha synuclein oligomers. This preliminary structural arrangement allows the probe to rapidly bind and respond to oligomers while maintaining quantitative specificity through the predetermined conformational change mechanism.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The probe utilizes dynamic conformational transitions between disordered and structured states that occur rapidly upon oligomer binding. This dynamic behavior enables both fast detection response and quantitative specificity, as the extent of conformational change correlates with oligomer presence and concentration.

Inventive Principle:

Principle #15Dynamics

3Reliability

If existing molecular probes are used, then detection can occur, but cross-reactivity with fibrils prevents specific oligomer detection

Engineering Contradiction:

Improvespecificity of oligomer detectionVSAvoidprobe responsiveness to different alpha synuclein forms

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The PG65 probe is segmented into distinct functional regions: an intrinsically disordered region for selective oligomer binding, a conformational switch element for signal transduction, and a fluorescent reporter for detection. This segmentation allows the probe to specifically recognize oligomers while remaining unresponsive to fibrils, resolving the contradiction between reliability and adaptability.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The conformational switch element acts as an intermediary between oligomer binding and fluorescence signal generation. This intermediary component ensures that fluorescence is only produced when the probe specifically binds to oligomers in the correct conformational state, preventing cross-reactivity with fibrils while maintaining probe versatility.

Inventive Principle:

Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

PG65 enables rapid, specific, and quantitative detection of αS oligomers, distinguishing them from monomers and fibrils, and is sensitive enough to detect oligomers at physiological concentrations, potentially aiding in the development of therapeutic agents and diagnostics for Parkinson's disease.

Implementation Method 1

conformation-sensitive fluorescence

Methodology Applied

Scientific EffectFluorescence: Fluorescence

Implementation Method 2

FlAsH fluorescence, which is known to be highly sensitive to protein conformational changes

Methodology Applied

Scientific EffectConformation-dependent fluorescence signaling: Fluorescence

Data Source

PatentUS9261514B2Conformational-switching fluorescent protein probe for detection of alpha synuclein oligomers

Publication Date: 2016.02.16 NEW YORK UNIV

AI summary

A conformation-switching fluorescent protein probe for detection of alpha synuclein oligomers using an alpha synuclein (αS) variant, PG65 (SEQ ID NO: 4), together with a conformation-sensitive fluorescent molecule to create a molecular probe for rapid, specific, and quantitative detection of αS oligomers.